While mRNA encoding the myeloid cell marker CD11b (ITGAM) was expressed at equal levels in all breast tumour subgroups (Fig. 7a), mRNA of the anti-inflammatory markers CD163 and S100A9 were expressed at significantly higher levels in basal than luminal A breast tumours (Fig. 7a). This evidence concerns the gene CD163 and breast neoplasm.